My MVP Big Board Pick is RELV, they recently celebrated

New Post Public Reply Private Reply Replies (0) Message Board
Bible Feed RobInvest #224

My MVP Big Board Pick is RELV, they recently celebrated there 25th anniversary.

Epigenetics Holds Key to Healthier Future
Recent research shows potential of disease prevention through nutrition

ST. LOUIS, Mo., September 14, 2012 – The sequencing of the human genome was once hailed by scientists to be the harbinger of medical miracles. Yet, deciphering our DNA brought us no closer to understanding — much less finding effective preventive approaches for — major chronic diseases.

But new groundbreaking research is uncovering a higher level of complexity beyond genetic variation. Even better news: proper nutrition can produce positive changes at this higher level.

A recent article by the Associated Press highlighted new data the Encyclopedia of DNA Elements (ENCODE) project recently published in Nature – the international weekly journal of science.

“The scientific establishment has finally acknowledged that there is more than just DNA or the genome to explain how chronic diseases develop and how the environment, like nutrition and lifestyle, can have profound effects in altering our health,” said Dr. Alfredo Galvez, renowned research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at the Missouri Plant Science Center.

What is the epigenome?
The genome is your body’s complete set of DNA and genes. We have more than 300 cell types — skin cells, liver cells, brain cells, etc. — that look and function differently even though they have the same DNA.

The epigenome is made up of the DNA packaging material called histones and chemicals that tell the genome what to do. These chemicals can turn different genes on or off to create different types of cells. For example, the epigenome tells your skin cells to behave like skin cells, liver cells like liver cells, and so on.


Nutrition’s Effect on DNA
The chemical compounds that comprise and affect the epigenome come from natural sources such as food, or man-made sources such as medicines. Research shows that changes in the epigenome can trigger diseases such as heart disease, autoimmune diseases and diabetes.

Our food provides nutrients necessary for methylation of DNA, an essential biochemical process that affects the expression of genes. DNA methylation can be improved or inhibited by our nutritional intake. For example, choline — a micronutrient found in cauliflower — can improve fetal brain development by improving DNA methylation.

The release of genes that cause inflammation can also be affected by nutrition. For example, resveratrol — a micronutrient found in grapes — can reduce symptoms of colitis by reducing the effect of inflammatory genes.

Lunasin: The Future of Nutritional Genomics
One of the most exciting discoveries in nutritional genomics is a soy peptide called lunasin .

Dozens of clinical studies have already documented lunasin’s positive effects on the epigenome. A recent study from Purdue University showed how lunasin enhances innate immunity – the ability of the body to resist damaging effects from chemical, bacterial and viral toxins. Many more clinical studies are in the works as lunasin research continues at top institutions across the country.

“Changes in the epigenome can cause serious diseases. Lunasin attaches to the histones and helps the epigenome function properly, so that these changes do not occur in the cells,” explained Galvez.

How Lunasin Works
Lunasin nourishes - provides the nutritional fuel to promote optimal expression of genes required for normal cell function.
Lunasin protects - reduces inflammation and cell damage caused by free radicals and other environmental hazards. Provides protection in two ways:
1. Prevention . Activates the expression of genes that help reduce cell damage and prevents the expression of genes that can cause cell damage.
2. Maintenance . Helps remove damaged cells from the body that may cause chronic health problems.

LunaRich Maximizes Lunasin Levels
Reliv International is bringing lunasin to the public through LunaRich™ soy powder . LunaRich maximizes lunasin content and contains five to ten times more lunasin than ordinary soy powder.

LunaRich is exclusively available from Reliv International, Inc. — a wellness company with a 25-year history of providing optimal nutritional supplements. Learn more at reliv.com .

About Reliv International, Inc.
Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition , weight loss , athletic performance , digestive health , women's health , anti-aging and healthy energy . The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at www.reliv.com , or on Facebook , Twitter or YouTube .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Your Rights as a Humacyte, Inc. Investor

Updated Category News Views 110

Understanding Your Rights as a Humacyte, Inc. Investor Humacyte, Inc. (NASDAQ: HUMA) has recently captured the attention of investors due to certain legal developments affecting its share value. If you are a shareholder who purchased shares during the specific class period of May 10, 2024, to October 17, 2024, you may want to take active steps to protect your investment...

Continue Reading
Jim Chanos Raises Concerns About Oracle's Accounting Issues

Updated Category News Views 552

Chanos Questions Oracle's Accounting Practices Notable short-seller Jim Chanos has recently highlighted some serious concerns regarding Oracle Corp's accounting integrity. He has voiced skepticism about the company's massive project backlog, especially a significant $300 billion deal partnered with OpenAI, emphasizing that its operational realization is years away and...

Continue Reading
Cyrus Biotechnology Advances Novel IgG Therapy with No Antibodies

Updated Category News Views 171

Promising Developments by Cyrus Biotechnology Cyrus Biotechnology, Inc. has unveiled groundbreaking data showcasing the effectiveness of its engineered IgG-degrading enzyme, CYR241, in a unique rabbit redosing model. This enzyme demonstrates significant therapeutic activity without the formation of anti-drug antibodies (ADAs) upon repeated administration. Understanding...

Continue Reading
GreenPower Motor Company: Strengthening Its Financial Future

Updated Category News Views 241

GreenPower Motor Company Secures New Term Loan Funding GreenPower Motor Company Inc. (NASDAQ: GP), an innovator in the production and distribution of all-electric medium and heavy-duty vehicles, recently completed the closing of the fifth tranche of its secured term loan offering. This strategic move aims to bolster its operational capabilities, particularly in the cargo,...

Continue Reading
Unlocking the Future: Insights into the Cloud Industry 2025

Updated Category News Views 226

The Promising Future of the Global Cloud Industry The global cloud industry is on a fast track to remarkable growth. Recent research indicates that the market is poised to expand from approximately USD 1,091.4 billion in one year to an impressive USD 1,256.8 billion by 2025. This represents a noteworthy year-over-year increase of about 15.1%. With such staggering figures,...

Continue Reading